Chiral methionine oxidation reagents reveal stereospecific proteome modifications

This study introduces enantiomeric oxaziridine reagents to map stereospecific methionine oxidation sites across proteomes, demonstrating that chiral regulation of these modifications can allosterically inhibit protein function and amplify specific oxidative stress responses.

The Gist

The Big Idea: The "Left-Handed" and "Right-Handed" Switch

Imagine your body is a massive, bustling city made of billions of tiny machines called proteins. These machines do everything from digesting food to fighting infections.

Inside these machines, there are specific parts made of an amino acid called Methionine. Think of Methionine as a tiny, sensitive light switch on these machines.

Sometimes, due to stress or pollution (what scientists call "oxidative stress"), this switch gets flipped. But here's the twist: because of the laws of chemistry, this switch can be flipped in two different ways, just like your hands. You have a left hand and a right hand. They look similar, but you can't stack them perfectly on top of each other. In chemistry, this is called chirality.

• The Problem: Scientists knew that these switches could be flipped, but they didn't have a good way to tell which hand (Left or Right) was flipped on which specific machine in the entire city. It was like trying to find a single broken light switch in a city of skyscrapers without a map.
• The Consequence: If the wrong switch is flipped, the machine might stop working, or worse, start causing damage to the rest of the city.

The Solution: The "Chiral Detective" (ChURRO)

The researchers in this paper invented a new tool called ChURRO (which stands for Chiral Unveiling by Redox-based Reactivity with Oxaziridines).

Think of ChURRO as a pair of magnetic gloves:

1. One glove is shaped perfectly for a Left-Handed switch.
2. The other glove is shaped perfectly for a Right-Handed switch.

When the researchers put these gloves on the proteins, the gloves only stick to the switches that match their shape. If a switch is "Left-handed," only the Left Glove sticks. If it's "Right-handed," only the Right Glove sticks.

Once the glove sticks, it leaves a glowing tag behind. This allows the scientists to take a photo of the entire city (the proteome) and see exactly which machines have their switches flipped, and in which direction.

What They Discovered: The "Secret Control Room"

Using their new detective tools, the scientists found something amazing:

1. It's Not Random: The switches aren't flipped randomly. The shape of the machine itself (the protein's structure) decides which way the switch flips. Some machines are built in a way that only allows the "Right-Handed" switch to flip, while others only allow the "Left-Handed" one.
2. The "BPHL" Machine: They focused on one specific machine called BPHL. It lives in the power plant of the cell (the mitochondria). Its job is to clean up a toxic waste product called HCTL.
   • They found that the "Right-Handed" switch on BPHL (at position M69) acts like a deadbolt lock.
   • When this specific switch flips to the "Right" side, the deadbolt locks, and the machine stops cleaning up the toxic waste.
   • This causes the toxic waste (HCTL) to build up and start gluing other proteins together, causing chaos and damage in the cell.

The "Eraser" and the Chain Reaction

The body has repair crews called Msr enzymes that can fix these switches.

• There is a crew that fixes the "Left" switches (MsrA).
• There is a crew that fixes the "Right" switches (MsrB2).

The study showed that when the cell is under stress, the "Right" switch on the BPHL machine flips. If the "Right" repair crew (MsrB2) is missing or too slow, the deadbolt stays locked. The BPHL machine shuts down, the toxic waste builds up, and it starts damaging other important proteins (like the SOD1 enzyme, which is like the cell's fire extinguisher).

Why This Matters

This paper is a breakthrough because:

• It's a New Map: Before this, scientists couldn't easily see these "handed" switches. Now, they have a map of where they are and what they do.
• New Treatments: Many diseases (like heart disease, Alzheimer's, and diabetes) are linked to this kind of protein damage. By understanding exactly which switch is broken, doctors might be able to design drugs that specifically unlock that deadbolt or boost the repair crew, rather than just treating the symptoms.

In a nutshell: The scientists built a pair of specialized gloves to find out which "handed" switches are broken in our body's machines. They found that when a specific "Right-Handed" switch breaks on a cleaning machine, it causes a toxic chain reaction that damages the whole cell. This opens the door to fixing these switches to treat diseases.

Technical Summary

1. The Problem

Methionine (Met) residues in proteins are highly susceptible to oxidation by reactive oxygen species (ROS) or monooxygenases, converting them into methionine sulfoxide (MetO). This oxidation introduces a chiral center at the sulfur atom, creating two distinct diastereomers: (S)-MetO and (R)-MetO.

• Current Knowledge Gap: While it is well-established that specific enzymes, Methionine Sulfoxide Reductase A (MsrA) and MsrB, stereospecifically reduce (S)-MetO and (R)-MetO respectively, the extent to which oxidation itself is stereospecific in living systems remains unclear.
• The Challenge: Historically, identifying which specific Met residues are oxidized to a specific chirality (pro-(S) vs. pro-(R)) across a whole proteome has been elusive. Most studies relied on purified proteins and enzymes, failing to capture the complexity of the cellular environment where protein microenvironments might dictate stereoselectivity. Without tools to distinguish these chiral marks, the functional consequences of specific chiral oxidation events (e.g., allosteric regulation) remain largely unexplored.

2. Methodology: The ChURRO Platform

The authors developed a chemical proteomics platform called ChURRO (Chiral Unveiling by Redox-based Reactivity with Oxaziridines) to systematically map prochiral Met oxidation sites.

• Chemical Probes: They synthesized a library of ten enantiomeric oxaziridine probes. These reagents react with Met residues to form sulfilimine adducts, which serve as isoelectronic proxies for MetO.
  • The probes feature a chiral C-phenyl directing group to engage with the protein microenvironment.
  • The library was screened, and (S)- and (R)-ChURRO-2 were selected as the optimal probes due to high labeling efficiency, stability, and stereoselectivity.
• Workflow:
  1. Labeling: Proteomes (cell lysates, purified mitochondria, or purified proteins) are treated with equimolar doses of (S)- or (R)-ChURRO-2.
  2. Tagging: The oxaziridine adducts are tagged with isotopically light or heavy desthiobiotin via Cu-catalyzed click chemistry (CuAAC).
  3. Enrichment & Digestion: Samples are combined, enriched via streptavidin, digested with trypsin, and analyzed by LC-MS/MS.
  4. Quantification: The ratio of light (S-labeled) to heavy (R-labeled) peptides identifies sites with stereospecific bias.
• Validation Models:
  • Genetic Perturbation: HEK-293T cells were subjected to siRNA knockdown of MsrA or MsrB2, followed by oxidative stress (paraquat). This created "mirrored" models where specific chiral MetO forms accumulated because their corresponding reductase was absent.
  • Mitochondrial Profiling: Highly purified mitochondria from mouse liver were analyzed to focus on a redox-active subcellular compartment.
  • Structural Analysis: Identified sites were mapped against AlphaFold structures to analyze Ramachandran angles ($\phi, \psi$) and steric crowding (partial sphere exposure, pPSE).

3. Key Contributions

• Development of ChURRO: A novel chemical toolset capable of distinguishing pro-(S) and pro-(R) methionine oxidation sites at the proteome-wide level.
• Discovery of Stereospecific Oxidation: Demonstrated that Met oxidation is not random; specific protein microenvironments (secondary structure and steric constraints) dictate whether a Met residue is preferentially oxidized to the (S) or (R) form.
• Functional Linkage: Established a direct causal link between a single chiral oxidation event on a specific protein and downstream physiological consequences (amplification of protein damage).

4. Key Results

A. Proteome-Wide Mapping

• In HEK-293T cells and mouse liver mitochondria, the platform identified 175 redox-sensitive methionines (133 pro-(S) and 42 pro-(R)).
• Selectivity: There was virtually no cross-reactivity; (S)-ChURRO-2 did not label pro-(R) sites and vice versa.
• Therapeutic Relevance: ~50% of the identified sites reside on "undruggable" proteins, suggesting these chiral marks represent new regulatory nodes for therapeutic intervention.
• Structural Correlates:
  • Pro-(R) sites are strongly associated with right-handed $\alpha$-helices.
  • Pro-(S) sites prefer $\beta$-sheet folds.
  • Steric Environment: Pro-(S) sites reside in more sterically encumbered environments compared to pro-(R) sites.

B. Case Study: BPHL (Biphenyl Hydrolase-Like Protein)

The authors focused on M69 of the mitochondrial enzyme BPHL, a pro-(R) site.

• Mechanism: M69 is located in an allosteric hydrophobic pocket near the catalytic triad.
• Oxidation Effect: Oxidation to (R)-MetO at M69 causes the sulfoxide zwitterion to hydrogen-bond with the catalytic serine, physically obstructing the substrate binding site.
• Kinetics: This results in a mixed inhibition mechanism, significantly increasing the $K_M$ for the native substrate (homocysteine thiolactone, HCTL) and reducing $k_{cat}$.
• Reversibility: The inhibition is reversed by MsrB2 (the (R)-MetO reductase) but not MsrA.
• Consequence: Inactivation of BPHL leads to an accumulation of HCTL.

C. Downstream Pathological Impact: N-Homocysteinylation

• The Cascade: Accumulated HCTL (due to BPHL inactivation) reacts with protein amines, causing N-homocysteinylation, a toxic post-translational modification linked to protein aggregation and neurodegeneration.
• Validation:
  • In cells lacking MsrB2, oxidative stress led to a 2-fold increase in global protein N-homocysteinylation.
  • This increase was rescued by overexpressing wild-type BPHL but not in MsrB2 KO cells, confirming the pathway: MsrB2 loss $\rightarrow$ (R)-Met69 oxidation $\rightarrow$ BPHL inhibition $\rightarrow$ HCTL accumulation $\rightarrow$ Global N-homocysteinylation.
• Specific Target: The proteome-wide analysis identified K76 on SOD1 as a major N-homocysteinylated site. This modification attenuates SOD1 activity, creating a feedback loop that exacerbates oxidative stress.

5. Significance

• Paradigm Shift: The paper challenges the dogma that Met oxidation is a non-specific, random event. It proves that protein structure creates "privileged" sites for stereospecific oxidation, functioning as a regulatory code.
• Single-Atom Regulation: It demonstrates that a single-atom chiral modification (Met $\to$ (R)-MetO) can act as an allosteric switch to regulate enzyme activity (BPHL) and trigger a cascade of cellular damage.
• Disease Mechanism: It provides a molecular mechanism linking oxidative stress, chiral Met oxidation, and the accumulation of toxic N-homocysteinylation, offering new insights into the pathogenesis of neurodegenerative and cardiovascular diseases.
• Tool Development: The ChURRO platform offers a generalizable method for characterizing chiral PTMs, potentially applicable to other redox-sensitive residues or chiral modifications in the future.